Claims:1. An anti-glycation composition comprising:
a. phytic acid; and
b. (R)-(-)-2-oxothiazolidine-4-carboxylic acid,
wherein phytic acid weight concentration is in the range of 0.00009-0.00012%, and (R)-(-)-2-oxothiazolidine-4-carboxylic acid weight concentration is in the range of 0.009-0.012%.
2. An anti-glycation formulation comprising:
a. phytic acid; and
b. (R)-(-)-2-oxothiazolidine-4-carboxylic acid,
wherein phytic acid weight concentration is in the range of 0.00009-0.00012%, and (R)-(-)-2-oxothiazolidine-4-carboxylic acid weight concentration is in the range of 0.009-0.012%.
3. The anti-glycation formulation as claimed in claim 2, further comprising at least one cosmetically acceptable ingredient.
4. The anti-glycation formulation as claimed in claim 3, wherein the cosmetically acceptable ingredient is selected from the group consisting of suitable carriers, diluents, skin benefitting agents, pH adjusting agents, emollients, moisturizing agents, antimicrobial agents, and excipients.
5. A method of preparing an anti-glycation composition comprising phytic acid; and (R)-(-)-2-oxothiazolidine-4-carboxylic acid, wherein phytic acid weight concentration is in the range of 0.00009-0.00012%, and (R)-(-)-2-oxothiazolidine-4-carboxylic acid weight concentration is in the range of 0.009-0.012%.
6. A method of preparing an anti-glycation formulation comprising phytic acid; (R)-(-)-2-oxothiazolidine-4-carboxylic acid, and suitable carriers, diluents, and excipients, wherein wherein phytic acid weight concentration is in the range of 0.00009-0.00012%, and (R)-(-)-2-oxothiazolidine-4-carboxylic acid weight concentration is in the range of 0.009-0.012%.
7. An anti-glycation formulation for topical application comprising:
a. phytic acid having weight concentration of 0.0001%;
b. (R)-(-)-2-oxothiazolidine-4-carboxylic acid having weight concentration of 0.01%;
c. acrylates/C10-30 alkyl acrylate cross-polymer having volume percentage of 0.07%;
d. glycerin having volume percentage of 5%;
e. butylene glycol having volume percentage of 2%;
f. D-Panthenol having volume percentage of 0.5%;
g. triethanolamine having volume percentage of 0.06%;
h. mineral oil having volume percentage of 4%;
i. cetyl alcohol having volume percentage of 3%;
j. glycol distearate having volume percentage of 3%;
k. dimethicone having volume percentage of 0.5%;
l. allantoin having volume percentage of 0.1%;
m. phenoxyethanol having volume percentage of 0.3%;
n. fragrance having volume percentage of 0.2%; and
o. water having volume percentage of 81.26%.
8. A method of preparing an anti-glycation formulation for topical application comprising: a) phytic acid having weight concentration of 0.0001%; b) (R)-(-)-2-oxothiazolidine-4-carboxylic acid having weight concentration of 0.01%; c) acrylates/C10-30 alkyl acrylate cross-polymer having volume percentage of 0.07%; d) glycerin having volume percentage of 5%; e) butylene glycol having volume percentage of 2%; f) D-Panthenol having volume percentage of 0.5%; g) triethanolamine having volume percentage of 0.06%; h) mineral oil having volume percentage of 4%; i) cetyl alcohol having volume percentage of 3%; j) glycol distearate having volume percentage of 3%; k) dimethicone having volume percentage of 0.5%; l) allantoin having volume percentage of 0.1%; m) phenoxyethanol having volume percentage of 0.3%; n) fragrance having volume percentage of 0.2%; and o) water having volume percentage of 81.26%.
9. A method for inhibiting glycation, said method comprising the steps:
a. obtaining a composition or a formulation comprising phytic acid; and (R)-(-)-2-oxothiazolidine-4-carboxylic acid, wherein phytic acid weight concentration is in the range of 0.00009-0.00012%, and (R)-(-)-2-oxothiazolidine-4-carboxylic acid weight concentration is in the range of 0.009-0.012%; and
b. contacting said composition or formulation with a site susceptible to glycation,
wherein said method inhibits glycation.
, Description:As Attached